Global Non-Opioid Pain Treatment Market Forecast 2018-2026

Publisher Name :
Date: 01-Jul-2018
No. of pages: 150

Key Findings

The global non-opioid pain treatment market is expected to progress over the forecast period of 2018-2026 by showcasing a CAGR of 16.62%. The market is being presented with opportunities like favourable regulatory scenario and increase in awareness about pain management drugs. These are expected to propel the market growth over the projected years.

Market Insights

The global non-opioid pain treatment market is segmented on the basis of therapeutics application and products. The therapeutic applications include orthopaedic/musculoskeletal pain, neuropathic pain, cancer pain and other pain. Presently, orthopaedic/musculoskeletal pain is the widely used therapeutic application. The product segment includes medical cannabis, menthol-containing, omega 3 fatty acid-containing, botulinum toxins and capsaicin-derived products.

Regional Insights

The regional segmentation of the global non-opioid pain treatment market is done into North America, Europe, Asia-Pacific and rest of the world. By the end of the forecast period of 2018-2026, the North American market is expected to account for the highest revenue share. The region has witnessed an increase in the number of osteoarthritis cases, which is acting as a major driver for its market's growth. In terms of CAGR, the APAC market is expected to race ahead over other regional markets, during the course of the forecast period. The key companies contributing to this region's growth are India, China and Japan.

Competitive Insights

Eminent market players in the global non-opioid pain treatment market are Allergan Plc, Aphria Inc, Aurora Cannabis Enterprises Inc, Bedrocan, Canopy Growth Corp, Cara Therapeutics, Centrexion Therapeutics, CHT Medical, Cronos Group, Gw Pharmaceuticals, Medical Marijuana Inc, Medropharm Gmbh, Tilray, and Vanway.

Global Non-Opioid Pain Treatment Market Forecast 2018-2026

Table of Contents

1. Research Scope
1.1. Study Goals
1.2. Scope of The Market Study
1.3. Who Will Find This Report Useful?
1.4. Study And Forecasting Years
2. Research Methodology
2.1. Sources of Data
2.1.1. Secondary Data
2.1.2. Primary Data
2.2. Top Down Approach
2.3. Bottom-Up Approach
2.4. Data Triangulation
3. Executive Summary
3.1. Market Summary
3.2. Key Findings
3.2.1. Medical Cannabis Holds The Largest Market Share And Is Anticipated To Grow At A Faster Rate During The Forecast Period
3.2.2. Orthopedic/Musculoskeletal Pain Is The Widely Used Therapeutic Application
4. Market Determinants
4.1. Market Drivers
4.1.1. Growing Geriatric Population
4.1.2. Easy And Effective Medications of Non-Opioids Drugs For Cancer Treatment
4.1.3. Increased Prevalence of Migraines
4.1.4. Promising Pipeline
4.2. Market Restraints
4.2.1. Preference For Alternative Therapies
4.2.2. Counterfeit Products Are Restricting The Market Growth
4.3. Market Opportunities
4.3.1. Favorable Regulatory Scenario
4.3.2. Increase In Awareness of Pain Management Drugs
4.4. Market Challenges
4.4.1. Short-Term Relief
4.4.2. Illegal Status of Cannabis Made It Difficult For Researchers To Study The Plant
4.4.3. Government Restrictions
5. Market Segmentation
5.1. Market By Products 2018-2026
5.1.1. Medical Cannabis
5.1.2. Menthol-Containing
5.1.3. Omega 3 Fatty Acid-Containing
5.1.4. Botulinum Toxins
5.1.5. Capsaicin-Derived
5.2. Market By Therapeutic Application 2018-2026
5.2.1. Orthopedic/Musculoskeletal Pain
5.2.2. Neuropathic Pain
5.2.3. Cancer Pain
5.2.4. Other Pain
6. Key Analytical
6.1. Porter's Five Forces Analysis
6.1.1. Threat of New Entrants
6.1.2. Threat of Substitutes
6.1.3. Bargaining Power of Buyers
6.1.4. Bargaining Power of Suppliers
6.1.5. Threat of Rivalry
6.2. Etymology of Pain And Pain Treatment
6.3. Patent Analysis
6.4. Developments In Non-Opioid Pain Treatment
6.5. Market Trends
6.5.1. Increase In R&D Activities
6.5.2. Use of Off-Label Drugs
6.5.3. Growing Focus On Emerging Economies
6.6. Key Buying Criteria
7. Geographical Analysis
7.1. North America
7.1.1. The United States
7.1.2. Canada
7.2. Europe
7.2.1. Germany
7.2.2. Italy
7.2.3. France
7.2.4. United Kingdom
7.2.5. Spain
7.2.6. Russia
7.2.7. Rest of Europe
7.3. Asia Pacific
7.3.1. China
7.3.2. Australia
7.3.3. Japan
7.3.4. India
7.3.5. South Korea
7.3.6. Rest of Asia-Pacific
7.4. Rest of World
7.4.1. Latin America
7.4.2. Middle East And Africa
8. Company Profiles
8.1. Allergan Plc
8.1.1. Company Overview
8.1.2. Product Portfolio
8.1.3. Strategic Initiatives
8.2. Aphria Inc.
8.2.1. Company Overview
8.2.2. Product Portfolio
8.2.3. Strategic Initiatives
8.3. Aurora Cannabis Enterprises Inc.
8.3.1. Company Overview
8.3.2. Product Portfolio
8.3.3. Strategic Initiatives
8.4. Bedrocan
8.4.1. Company Overview
8.4.2. Product Portfolio
8.4.3. Strategic Initiatives
8.5. Canopy Growth Corp.
8.5.1. Company Overview
8.5.2. Product Portfolio
8.5.3. Strategic Initiatives
8.6. Cara Therapeutics
8.6.1. Company Overview
8.6.2. Product Portfolio
8.6.3. Strategic Initiatives
8.7. Centrexion Therapeutics
8.7.1. Company Overview
8.7.2. Product Portfolio
8.7.3. Strategic Initiatives
8.8. Cht Medical
8.8.1. Company Overview
8.8.2. Product Portfolio
8.9. Cronos Group
8.9.1. Company Overview
8.9.2. Product Portfolio
8.9.3. Strategic Initiatives
8.10. Gw Pharmaceuticals
8.10.1. Company Overview
8.10.2. Product Portfolio
8.10.3. Strategic Initiatives
8.11. Medical Marijuana Inc.
8.11.1. Company Overview
8.11.2. Product Portfolio
8.11.3. Strategic Initiatives
8.12. Medropharm Gmbh
8.12.1. Company Overview
8.12.2. Product Portfolio
8.13. Tilray
8.13.1. Company Overview
8.13.2. Product Portfolio
8.13.3. Strategic Initiatives
8.14. Vanway
8.14.1. Company Overview
8.14.2. Product Portfolio

List of Tables

Table 1 Global Non-Opioid Pain Treatment Market By Geography 2018-2026
Table 2 Physiological Effects of Pain
Table 3 Extended-Release Trade Name Included In Opioid Rems 2017
Table 4 Extended-Release Generic Name Included In Opioid Rems 2017
Table 5 Adoption of Medical Cannabis Different Countries 2017 (%)
Table 6 Global Non-Opioid Pain Treatment Market By Products 2018-2026
Table 7 Global Non-Opioid Pain Treatment Market In Medical Cannabis By Therapeutic Application 2018-2026
Table 8 Cannabis Clinical Trials For Pain Treatment 2017
Table 9 Global Non-Opioid Pain Treatment Market In Menthol-Containing By Therapeutic Application 2018-2026
Table 10 Global Non-Opioid Pain Treatment Market In Omega 3 Fatty Acid-Containing By Therapeutic Application 2018-2026
Table 11 Botulinum Toxin Clinical Trials For Pain Treatment 2017
Table 12 Global Non-Opioid Pain Treatment Market In Botulinum Toxins By Therapeutic Application 2018-2026
Table 13 Botulinum Toxin Clinical Trials For Pain Treatment 2017
Table 14 Global Non-Opioid Pain Treatment Market In Capsaicin-Derived By Therapeutic Application 2018-2026
Table 15 Capsaicin-Derived Clinical Trials For Pain Treatment 2017
Table 16 Global Non-Opioid Pain Treatment Market By Therapeutic Application 2018-2026
Table 17 Global Non-Opioid Pain Treatment Market In Orthopedic/Musculoskeletal Pain By Product 2018-2026
Table 18 Global Non-Opioid Pain Treatment Market In Neuropathic Pain By Product 2018-2026
Table 19 Global Non-Opioid Pain Treatment Market In Cancer Pain By Product 2018-2026
Table 20 Global Non-Opioid Pain Treatment Market In Other Pain By Product 2018-2026
Table 21 Medical Cannabis Patents In The U.S. By Type, 2017 (%)
Table 22 Medical Cannabis Technologies Patents In The U.S. By Type 2017 (%)
Table 23 Number of Medical Cannabis Patents In The United States By Company 2017
Table 24 Number of Medical Cannabis Patents In The United States 2017
Table 25 Global Non-Opioid Pain Treatment Market By Geography 2018-2026
Table 26 North America Non-Opioid Pain Treatment Market 2018-2026
Table 27 The United States Non-Opioid Pain Treatment Market By Product 2018-2026
Table 28 The United States Non-Opioid Pain Treatment Market By Therapeutic Application 2018-2026
Table 29 Canada Non-Opioid Pain Treatment Market By Product 2018-2026
Table 30 Canada Non-Opioid Pain Treatment Market By Therapeutic Application 2018-2026
Table 31 Europe Non-Opioid Pain Treatment Market 2018-2026
Table 32 Germany Non-Opioid Pain Treatment Market By Products 2018-2026
Table 33 Germany Non-Opioid Pain Treatment Market By Therapeutic Application 2018-2026
Table 34 Italy Non-Opioid Pain Treatment Market By Products 2018-2026
Table 35 Italy Non-Opioid Pain Treatment Market By Therapeutic Application 2018-2026
Table 36 France Non-Opioid Pain Treatment Market By Products 2018-2026
Table 37 France Non-Opioid Pain Treatment Market By Therapeutic Application 2018-2026
Table 38 United Kingdom Non-Opioid Pain Treatment Market By Products 2018-2026
Table 39 United Kingdom Non-Opioid Pain Treatment Market By Therapeutic Application 2018-2026
Table 40 Spain Non-Opioid Pain Treatment Market By Products 2018-2026
Table 41 Spain Non-Opioid Pain Treatment Market By Therapeutic Application 2018-2026
Table 42 Russia Non-Opioid Pain Treatment Market By Products 2018-2026
Table 43 Russia Non-Opioid Pain Treatment Market By Therapeutic Application 2018-2026
Table 44 Asia Pacific Non-Opioid Pain Treatment Market 2018-2026
Table 45 China Non-Opioid Pain Treatment Market By Products 2018-2026
Table 46 China Non-Opioid Pain Treatment Market By Therapeutic Application 2018-2026
Table 47 Japan Non-Opioid Pain Treatment Market By Products 2018-2026
Table 48 Japan Non-Opioid Pain Treatment Market By Therapeutic Application 2018-2026
Table 49 Rest of World Non-Opioid Pain Treatment Market 2018-2026
Figures List
Figure 1 Global Non-Opioid Pain Treatment Market 2018-2026
Figure 2 Global Non-Opioid Pain Treatment Market In Medical Cannabis 2018-2026
Figure 3 Global Non-Opioid Pain Treatment Market In Menthol-Containing 2018-2026
Figure 4 Global Non-Opioid Pain Treatment Market In Omega 3 Fatty Acid-Containing 2018-2026
Figure 5 Global Non-Opioid Pain Treatment Market In Botulinum Toxins 2018-2026
Figure 6 Global Non-Opioid Pain Treatment Market In Capsaicin-Derived 2018-2026
Figure 7 Global Non-Opioid Pain Treatment Market In Orthopedic/Musculoskeletal Pain 2018-2026
Figure 8 Global Non-Opioid Pain Treatment Market In Neuropathic Pain 2018-2026
Figure 9 Global Non-Opioid Pain Treatment Market In Cancer Pain 2018-2026
Figure 10 Global Non-Opioid Pain Treatment Market In Other Pain 2018-2026
Figure 11 Non-Opioid Pain Treatments Patents In The United States By Type 2017 (%)
Figure 12 The United States Non-Opioid Pain Treatment Market 2018-2026
Figure 13 Canada Non-Opioid Pain Treatment Market 2018-2026
Figure 14 Germany Non-Opioid Pain Treatment Market 2018-2026
Figure 15 Italy Non-Opioid Pain Treatment Market 2018-2026
Figure 16 France Non-Opioid Pain Treatment Market 2018-2026
Figure 17 United Kingdom Non-Opioid Pain Treatment Market 2018-2026
Figure 18 Spain Non-Opioid Pain Treatment Market 2018-2026
Figure 19 Russia Non-Opioid Pain Treatment Market 2018-2026
Figure 20 Rest of Europe Non-Opioid Pain Treatment Market 2018-2026
Figure 21 China Non-Opioid Pain Treatment Market 2018-2026
Figure 22 Australia Non-Opioid Pain Treatment Market 2018-2026
Figure 23 Japan Non-Opioid Pain Treatment Market 2018-2026
Figure 24 India Non-Opioid Pain Treatment Market 2018-2026
Figure 25 South Korea Non-Opioid Pain Treatment Market 2018-2026
Figure 26 Rest of Asia-Pacific Non-Opioid Pain Treatment Market 2018-2026
Figure 27 Latin America Non-Opioid Pain Treatment Market 2018-2026
Figure 28 Middle East And Africa Non-Opioid Pain Treatment Market 2018-2026
  • Global Pain Management Drugs Market Research Report 2024
    Published: 08-Jan-2024        Price: US 2900 Onwards        Pages: 93
    Pain is complex, so there are many treatment options -- medications, therapies, and mind-body techniques. This report is mainly about The drugs for pain management. The global Pain Management Drugs market was valued at US$ 35360 million in 2023 and is anticipated to reach US$ 44550 million by 2030, witnessing a CAGR of 3.3% during The forecast period 2024-2030. The leading manufacturers in The industry are GSK, Pfizer and Grunenthal, which accounted for 14.42%, 13......
  • Global Pain Management Drugs Market Growth (Status and Outlook) 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 131
    According to our LPI (LP Information) latest study, the global Pain Management Drugs market size was valued at US$ 34590 million in 2023. With growing demand in downstream market, the Pain Management Drugs is forecast to a readjusted size of US$ 43780 million by 2030 with a CAGR of 3.4% during review period. The research report highlights the growth potential of the global Pain Management Drugs market. Pain Management Drugs are expected to show stable growth in the future market. However......
  • Global Opioids Drug Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 115
    According to our LPI (LP Information) latest study, the global Opioids Drug market size was valued at US$ 9831.4 million in 2023. With growing demand in downstream market, the Opioids Drug is forecast to a readjusted size of US$ 8616.1 million by 2030 with a CAGR of -1.9% during review period. The research report highlights the growth potential of the global Opioids Drug market. Opioids Drug are expected to show stable growth in the future market. However, product differentiation, reduci......
  • Global Methadone Hydrochloride Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 90
    According to our LPI (LP Information) latest study, the global Methadone Hydrochloride market size was valued at US$ 63 million in 2023. With growing demand in downstream market, the Methadone Hydrochloride is forecast to a readjusted size of US$ 88 million by 2030 with a CAGR of 5.0% during review period. The research report highlights the growth potential of the global Methadone Hydrochloride market. Methadone Hydrochloride are expected to show stable growth in the future market. Howev......
  • Global Opioids Drugs Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 02-Jan-2024        Price: US 3380 Onwards        Pages: 112
    Market Overview of Global Opioids Drugs market: According to our latest research, the global Opioids Drugs market looks promising in the next 5 years. As of 2022, the global Opioids Drugs market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. Opioids are a class of drugs that include the illegal drug heroin, synthetic opioids such as fentanyl, and pain relievers available legally by prescript......
  • Global Opioids Drug Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030
    Published: 01-Jan-2024        Price: US 3480 Onwards        Pages: 111
    According to our (Global Info Research) latest study, the global Opioids Drug market size was valued at USD 10340 million in 2023 and is forecast to a readjusted size of USD 9156.6 million by 2030 with a CAGR of -1.7% during review period. Opioids are a class of drugs that include the illegal drug heroin, synthetic opioids such as fentanyl, and pain relievers available legally by prescription, such as oxycodone (OxyContin®), hydrocodone (Vicodin®), codeine, morphine, and many others. The......
  • Global Methadone Hydrochloride Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030
    Published: 01-Jan-2024        Price: US 3480 Onwards        Pages: 87
    According to our (Global Info Research) latest study, the global Methadone Hydrochloride market size was valued at USD 66 million in 2023 and is forecast to a readjusted size of USD 90 million by 2030 with a CAGR of 4.6% during review period. Methadone Hydrochloride is a white, crystalline material that is water-soluble. It is an opioid used to treat pain or as maintenance therapy to help with detoxification in people with opioid dependence. Market Competition is not intense, as t......
  • Global Pain Management Drugs Market 2024 by Company, Regions, Type and Application, Forecast to 2030
    Published: 01-Jan-2024        Price: US 3480 Onwards        Pages: 131
    According to our (Global Info Research) latest study, the global Pain Management Drugs market size was valued at USD 36380 million in 2023 and is forecast to a readjusted size of USD 45230 million by 2030 with a CAGR of 3.2% during review period. Pain is complex, so there are many treatment options -- medications, therapies, and mind-body techniques. This report is mainly about the drugs for pain management. The leading manufacturers in the industry are GSK, Pfizer and Grune......
  • Global Fibromyalgia Drugs Market Research Report 2023, Forecast to 2028
    Published: 28-Dec-2023        Price: US 2680 Onwards        Pages: 167
    The FDA has approved three drugs to treat fibromyalgia: the antidepressants duloxetine (Cymbalta) and milnacipran (Savella), plus the anti-seizure medicine pregabalin (Lyrica). Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their goals while taking advantage of emerging oppo......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs